Page last updated: 2024-10-24

third ventricle development

Definition

Target type: biologicalprocess

The process whose specific outcome is the progression of the third ventricle over time, from its formation to the mature structure. The third ventricle is the narrow cleft inferior to the corpus callosum, within the diencephalon, between the paired thalami. Its floor is formed by the hypothalamus, its anterior wall by the lamina terminalis, and its roof by ependyma, and it communicates with the fourth ventricle by the cerebral aqueduct, and with the lateral ventricles by the interventricular foramina. [GO_REF:0000021, GOC:cls, GOC:dgh, GOC:dph, GOC:jid, ISBN:0838580343]

The third ventricle is a fluid-filled cavity located in the center of the brain, and its development is a complex process that begins during early embryonic development.

The third ventricle arises from the diencephalon, which is a primary vesicle of the developing brain. The diencephalon gives rise to several important structures, including the thalamus, hypothalamus, and epithalamus.

During the early stages of development, the diencephalon forms a hollow tube that is lined by neuroepithelial cells. These cells divide and differentiate into various types of neurons and glial cells. As the diencephalon expands, the tube begins to fold and form a cavity, which eventually becomes the third ventricle.

The development of the third ventricle is closely linked to the formation of the other brain ventricles and the development of the surrounding brain structures. The choroid plexus, a specialized structure located in the ventricle, is responsible for producing cerebrospinal fluid, which fills the ventricles and surrounds the brain and spinal cord.

**The following are the key steps involved in third ventricle development:**

* **Formation of the neural tube:** The first step in brain development is the formation of the neural tube, which is a hollow tube that will eventually give rise to the brain and spinal cord.
* **Differentiation of the diencephalon:** The diencephalon, a part of the neural tube, develops and differentiates to form the thalamus, hypothalamus, and epithalamus.
* **Folding of the diencephalon:** The diencephalon folds inward, creating a cavity that becomes the third ventricle.
* **Formation of the choroid plexus:** The choroid plexus develops within the third ventricle and is responsible for producing cerebrospinal fluid.
* **Growth and development of surrounding structures:** The thalamus, hypothalamus, and epithalamus grow and develop around the third ventricle, forming its boundaries.

**Factors influencing third ventricle development:**

* **Genetic factors:** Genes play a crucial role in the development of the brain, including the third ventricle. Mutations in specific genes can lead to malformations of the ventricle.
* **Environmental factors:** Exposure to certain toxins or infections during pregnancy can also affect brain development and lead to abnormalities in the third ventricle.
* **Hormones:** Hormones, such as thyroid hormone, play a role in brain development and can influence the formation of the third ventricle.

**Disorders of third ventricle development:**

* **Hydrocephalus:** A condition where there is an accumulation of cerebrospinal fluid in the ventricles, including the third ventricle, leading to increased pressure on the brain.
* **Holoprosencephaly:** A severe birth defect where the forebrain fails to develop properly, resulting in a single ventricle.
* **Diencephalic syndrome:** A group of disorders that affect the diencephalon, often involving abnormalities in the third ventricle.

**Significance of third ventricle development:**

* **Cerebrospinal fluid production and circulation:** The third ventricle plays a vital role in the production and circulation of cerebrospinal fluid, which is essential for protecting and nourishing the brain.
* **Communication between brain regions:** The third ventricle serves as a passageway for communication between different parts of the brain, particularly the thalamus and hypothalamus.
* **Regulation of endocrine function:** The hypothalamus, which borders the third ventricle, is a key regulator of endocrine function and plays a role in controlling hormones.

In summary, the development of the third ventricle is a complex and intricate process that is essential for the proper formation and function of the brain. Understanding the biological processes involved in third ventricle development is crucial for diagnosing and treating disorders that affect this vital structure.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Lysine-specific demethylase 2BA lysine-specific demethylase 2B that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q8NHM5]Homo sapiens (human)
Sodium/potassium-transporting ATPase subunit beta-2A sodium/potassium-transporting ATPase subunit beta-2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P14415]Homo sapiens (human)

Compounds (14)

CompoundDefinitionClassesRoles
deferipronedeferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
4-pyridonesiron chelator;
protective agent
lansoprazoleLansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.benzimidazoles;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
omeprazole5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
pantoprazolepantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
aromatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide
anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
rostafuroxinrostafuroxin: structure in first source
ouabaincardiac glycoside : Steroid lactones containing sugar residues that act on the contractile force of the cardiac muscles.

ouabain : A steroid hormone that is a multi-hydroxylated alpha-L-rhamnosyl cardenoloide. It binds to and inhibits the plasma membrane Na(+)/K(+)-ATPase (sodium pump). It has been isolated naturally from Strophanthus gratus.

Ouabain: A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE.
11alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone
anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
digitoxindigitoxin : A cardenolide glycoside in which the 3beta-hydroxy group of digitoxigenin carries a 2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl trisaccharide chain.

Digitoxin: A cardiac glycoside sometimes used in place of DIGOXIN. It has a longer half-life than digoxin; toxic effects, which are similar to those of digoxin, are longer lasting. (From Martindale, The Extra Pharmacopoeia, 30th ed, p665)
cardenolide glycosideEC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor
digoxindigoxin : A cardenolide glycoside that is digitoxin beta-hydroxylated at C-12. A cardiac glycoside extracted from the foxglove plant, Digitalis lanata, it is used to control ventricular rate in atrial fibrillation and in the management of congestive heart failure with atrial fibrillation, but the margin between toxic and therapeutic doses is small.

Digoxin: A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
cardenolide glycoside;
steroid saponin
anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
digitoxigenindigitoxigenin : A 5beta-cardenolide that is 5beta-cardanolide with hydroxy substituents at the 3beta- and 14beta-positions and double bond unsaturation at C(20)-C(22).

Digitoxigenin: 3 beta,14-Dihydroxy-5 beta-card-20(22)enolide. A cardenolide which is the aglycon of digitoxin. Synonyms: Cerberigenin; Echujetin; Evonogenin; Thevetigenin.
14beta-hydroxy steroid;
3beta-hydroxy steroid
phakellistatin 2phakellistatin 2: isolated from the marine sponge Phakellia carteri; structure in first source
digitoxigenin monodigitoxosidedigitoxigenin monodigitoxoside: RN given refers to (ribo-3beta,5beta)-isomer
evomonosideevomonoside : A cardenolide glycoside consisting of digitoxigenin having an alpha-L-rhamnosyl moiety attached at the O(3)-position.

evomonoside: a cytotoxic cardiac glycoside from Lepidium apetalum; RN refers to (3beta,5beta)-isomer
cardenolide glycoside
halisulfate 1halisulfate 1: an isocitrate lyase inhibitor sesterterpene sulfate from sponge, Hippospongia sp.; structure in first sourceorganic molecular entitymetabolite
3-[[2-(2-pyridinyl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)-4-pyrimidinyl]amino]propanoic acidorganonitrogen heterocyclic compound